FOXO3 longevity genotype mitigates the increased mortality risk in men with a cardiometabolic disease

Randi Chen1, Brian J Morris1,2,3, Timothy A Donlon1,4,5

  • 1Department of Research, Kuakini Medical Center, Honolulu, HI 96817, USA.

Aging
|December 1, 2020
PubMed

Insights

The longevity gene FOXO3 extends lifespan in individuals with cardiometabolic diseases (CMD). This FOXO3 longevity genotype offers protection against cardiometabolic stress, improving survival in at-risk populations.

Area of Science:

  • Genetics
  • Longevity research
  • Cardiovascular health

Background:

  • The gene FOXO3 is recognized as a significant longevity gene.
  • Previous research has not clarified if FOXO3 variants protect against mortality in all individuals or only those with age-related diseases.

Purpose of the Study:

  • To investigate whether longevity-associated FOXO3 genetic variants are associated with mortality protection in individuals with and without cardiometabolic disease (CMD).

Main Methods:

  • Examined longevity-associated FOXO3 single nucleotide polymorphisms in a haplotype block.
  • Analyzed mortality data in 3,584 elderly American men of Japanese ancestry (2,512 with CMD, 1,072 without).
  • Assessed baseline CMD conditions including diabetes, hypertension, and coronary heart disease (CHD).

Main Results:

  • In individuals with CMD, longevity-associated FOXO3 alleles were linked to significantly longer lifespan (hazard ratio 0.81).
  • Men with CMD and the FOXO3 longevity genotype exhibited survival rates similar to men without CMD.
  • No association between FOXO3 longevity alleles and lifespan was observed in men without CMD.

Conclusions:

  • The FOXO3 longevity genotype appears to increase lifespan specifically in individuals at risk due to cardiometabolic stress.
  • This study provides new insights into the role of FOXO3 in longevity, particularly its protective effects against mortality in the context of aging-related diseases.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
182
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
8.6K
X-linked Traits01:19

X-linked Traits

In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
57.3K
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
10.9K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
591
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
204